Cross-linked protein crystals for vaccine delivery

Proceedings of the National Academy of Sciences of the United States of America

Volumn 96, Issue 17, 1999, Pages 9469-9474

  St Clair, Nancy ^a   Shenoy, Bhami ^a   Jacob, Lawrence D ^b   Margolin, Alexey L ^a  

^a Altus Pharmaceuticals Inc   (United States)

^b Inveresk Research   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN; VACCINE;

ADJUVANT THERAPY; ARTICLE; BIODEGRADATION; CRYSTALLIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHESIS; IMMUNE RESPONSE; IMMUNOGENICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CROSS LINKING;

ANIMALS; ANTIBODY FORMATION; COMPUTER SIMULATION; CROSS-LINKING REAGENTS; CRYSTALLIZATION; DRUG DELIVERY SYSTEMS; FEMALE; FREUND'S ADJUVANT; HUMANS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTEINS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; VACCINES;

EID: 0033578323     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.96.17.9469     Document Type: Article

References (40)

1. Newman, M. J. & Powell, M. F. (1995) in Vaccine Design: The Subunit and Adjuvant Approach, eds. Powell, M. F. & Newman, M. J. (Plenum, New York), pp. 1-42.
2. Allsopp, C. E., Plebansky, M., Gilbert, S., Sinden, R. E., Harris, S., Frankel, G., Dougan, G., Hioe, C., Nixon, D., Paoletti, E., et al. (1996) Eur. J. Immunol. 8, 1951-1959.
3. Vogel, F. R. & Powell, M. F. (1995) in Vaccine Design: The Subunit and Adjuvant Approach., eds. Powell, M. F. & Newman, M. J. (Plenum, New York), pp. 141-228.
4. Kline, D., Hanes, J. & Langer, R. (1996) in Microparticulate Systems for the Delivery of Proteins and Vaccines, eds. Cohen, S. & Bernstein, H. (Dekker, New York), pp. 349-379.
5. Gregoriadis, G. (1990) Immunol. Today 11, 89-97.
6. Raychaudhuri, S., Tonks, M., Carbone, F., Ryskamp, T., Mrrow, W. J. & Hanna, N. (1992) Proc. Natl. Acad. Sci. USA 89, 8308-8312.
7. Morein, B., Sundquist, B., Hoglund, S., Dalsgaard, K. & Osterhaus, A. D. M. E. (1984) Nature (London) 308, 457-459.
8. Newman, M. J., Wu, J. Y., Gardner, B. H., Munroe, K. J., Leombruno, D., Recchia, J., Kensil, C. R. & Coughlin, R. T. (1992) J. Immunol. 148, 2357-62.
9. Hanes, J., Cleland, J. L. & Langer, R. (1997) Adv. Drug Delivery Rev. 28, 97-119.
10. Schwendeman, S. P., Cardamone, M., Klibanov, A. M., Langer, R. & Brandon, M. R. (1996) in Microparticulate Systems for the Delivery of Proteins and Vaccines, eds. Cohen, S. & Bernstein, H. (Dekker, New York), pp. 1-49.
11. Shirodkar, S., Hutchinson, R. L., Perry, D. L., White, J. L. & Hem, S. L. (1990) Pharm. Res. 7, 1282-1288.
12. McPherson, A. (1989) Preparation and Analysis of Protein Crystals (Krieger, Malabar, FL).
13. Margolin, A. L. (1996) Trends Biotechnol. 14, 223-230.
14. Lalonde, J. J., Govardhan, C. P., Khalaf, N. K., Martinez, O. G., Visuri, K. J. & Margolin, A. M. (1995) J. Am. Chem. Soc. 117, 6845-6852.
15. Govardhan, C. & Margolin, A. L. (1995) Chem. Ind. 689-693.
16. Persichetti, R. A., St. Clair, N. L., Griffith, J. P., Navia, M. A. & Margolin, A. L. (1995) J. Am. Chem. Soc. 117, 2732-2737.
17. Vilenchik, L. Z., Griffith, J. P., St. Clair, N., Navia, M. A. & Margolin, A. L. (1998) J. Am. Chem. Soc. 18, 4290-4294.
18. Verdier, J.-M., Ewart, K. V., Griffith, M. & Hew, C. L. (1996) Eur. J. Biochem., 241, 740-743.
19. Perl-Treves, D., Kessler, N., Izhaky, D. & Addadi, L. (1996) Chem. Biol. 3, 567-577.
20. Burroughs, J. N., O'Hara, R. S., Smale, C. J., Hamblin, C., Wallon, A., Armstrong, R. & Mertens, P. P. C. (1994) J. Gen. Virol. 75, 1849-1857.
21. Wade-Evans, A. M., Pullen, L., Hamblin, C., O'Hara, R., Burroughs, J. N. & Mertens, P. P. C. (1997) J. Gen. Virol. 78, 1611-1616.
22. Dong, A., Prestrelski, S. J., Allison, S. D. & Carpenter, J. F. (1995) J. Pharmacol. Sci. 84, 415-424.
23. Heinrikson, R. L. & Meredith, S. C. (1984) Anal. Biochem. 136, 65-74.
24. Herbert, W. J. (1976) Immunology 14, 301-318.
25. White, R. G. (1976) Annu. Rev. Microbiol. 30, 579-600.
26. Gupta, R. K., Rost, B. E., Relyveld, E & Siber, G. R. (1995) in Vaccine Design: The Subunit and Adjuvant Approach., eds. Powell, M. F. & Newman, M. J. (Plenum, New York), pp. 1-42.
27. Eldridge, J. H., Staas, J. K., Meulbroek, J. A., Tice, T. R. & Gilley, R. M. (1991) Infect. Immun. 59, 2978-2986.
28. Eldridge, J. H., Staas, J. K., Meulbroek, J. A., McGhee, J. R., Tice, T. R. & Gilley, R. M. (1991) Mol. Immunol. 28, 287-294.
29. Weber, P. (1997) Methods Enzymol. 276, 13-22.
30. Matthews, B. W. (1968) J. Mol. Biol. 33, 491-497.
31. He, X. M. & Carter, D. C. (1992) Nature (London) 16, 209-215.
32. Carter, D. C., Chang, B., Ho, J. X., Keeling, K.; Krishnasami, Z. (1994) Eur. J. Biochem. 226, 1049-1052.
33. McAleer, W. J., Buynak, E. B., Maigetter, R. Z. Wampler, D. E., Miller, W. J. & Hilleman, M. R. (1984) Nature (London) 307, 178-80.
34. Austin, J. W., Doig, P., Stewart, M. & Trust, T. J. (1992) J. Bacteriol. 174, 7470-7473.
35. Adams, S. E. & Kingsman, A. S. (1995) in Vaccine Design: The Subunit and Adjuvant Approach., eds. Powell, M. F. & Newman, M. J. (Plenum, New York), pp. 769-786.
36. Gilbert, S. C., Plebansky, M., Harris, S. J., Allsopp, C. E., Thomas, R., Layton, G. T. & Hill, A. V. (1997) Nat. Biotechnol. 14, 1280-1284.
37. Sedic, C., Saron, M., Sarraseca, J., Casal, I. & Leclerc, C. (1997) Proc. Natl. Acad. Sci. USA 94, 7503-7508.
38. Tabata, Y. & Ikada, Y. (1988) J. Biomed. Mater. Res. 22, 837-858.
39. Raychaudhuri, S. & Rock, K. L. (1998) Nat. Biotechnol. 16, 1025-1031.
40. Speidel, K., Osen, W., Faath, S., Hilgert, I., Obst, R., Braspenning, J., Momburg, F, Hammerling, G. J. & Rammensee, H. G. (1997) Eur. J. Immunol. 27, 2391-2399.